Page last updated: 2024-08-26

3,3'-dioctadecylindocarbocyanine and Malignant Melanoma

3,3'-dioctadecylindocarbocyanine has been researched along with Malignant Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, Z; Wang, J; Yang, T; Yin, J; Zhang, Q; Zhang, X1
Abbas, A; Braun, RD; Bukhari, SO; Wilson, W1

Other Studies

2 other study(ies) available for 3,3'-dioctadecylindocarbocyanine and Malignant Melanoma

ArticleYear
Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature.
    Journal of drug targeting, 2011, Volume: 19, Issue:1

    Topics: Animals; Carbocyanines; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Endocytosis; Endothelial Cells; Flow Cytometry; Fluorescent Dyes; Humans; Integrins; Melanoma; Mice; Micelles; Microscopy, Confocal; Paclitaxel; Particle Size; Peptides, Cyclic; Polyethylene Glycols; Polyglactin 910

2011
Hemodynamic parameters in blood vessels in choroidal melanoma xenografts and rat choroid.
    Investigative ophthalmology & visual science, 2002, Volume: 43, Issue:9

    Topics: Animals; Blood Flow Velocity; Carbocyanines; Choroid; Choroid Neoplasms; Erythrocytes; Fluorescent Dyes; Hematocrit; Hemodynamics; Melanoma; Microcirculation; Microscopy, Fluorescence; Models, Animal; Neovascularization, Pathologic; Rats; Rats, Mutant Strains; Rhodamines; Transplantation, Heterologous; Video Recording

2002